Detalhe da pesquisa
1.
Microlyse: a thrombolytic agent that targets VWF for clearance of microvascular thrombosis.
Blood
; 139(4): 597-607, 2022 01 27.
Artigo
Inglês
| MEDLINE | ID: mdl-34752601
2.
A mutation in the kringle domain of human factor XII that causes autoinflammation, disturbs zymogen quiescence, and accelerates activation.
J Biol Chem
; 295(2): 363-374, 2020 01 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31771982
3.
Detecting oral kallikrein-targeting therapy through triggered contact activation: A phase I study.
J Allergy Clin Immunol
; 146(6): 1446-1449.e5, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32360287
4.
Targeted SERPIN (TaSER): A dual-action antithrombotic agent that targets platelets for SERPIN delivery.
J Thromb Haemost
; 20(2): 353-365, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34653316
5.
Thrombotic Events in COVID-19 Are Associated With a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity.
Front Med (Lausanne)
; 8: 650129, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33968958
6.
The Fibronectin Type II Domain of Factor XII Ensures Zymogen Quiescence.
Thromb Haemost
; 120(3): 400-411, 2020 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-31940673
7.
Heparin Forms Polymers with Cell-free DNA Which Elongate Under Shear in Flowing Blood.
Sci Rep
; 9(1): 18316, 2019 12 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31797980
8.
Truncation of ADAMTS13 by Plasmin Enhances Its Activity in Plasma.
Thromb Haemost
; 118(3): 471-479, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29534248